rmance, goals, strategic actions and initiatives and similar intentions and beliefs, including phrases "are expected", "is expected", "help accelerate", "continuous improvement", "enhance our leadership position" and other statements regarding the Company's expectations, goals, beliefs, intentions and the like regarding future sales and other matters. These statements are based on assumptions regarding Company operations, investments and acquisitions and conditions in the markets the Company serves. The Company believes these assumptions are reasonable and well founded. The forward looking statements in this release are subject to risks and uncertainties, including, among others, certain economic, political and technological factors referred to in the Company's current Form 10-K on file with the Securities and Exchange Commission.
About Sigma-Aldrich: Sigma-Aldrich is a leading Life Science and High Technology company. Its biochemical and organic chemical products and kits are used in scientific research, including genomic and proteomic research, biotechnology, pharmaceutical development and as key components in pharmaceutical, diagnostic and other high technology manufacturing. The Company has customers in life science companies, university and government institutions, hospitals, and in industry. Over one million scientists and technologists use its products. Sigma-Aldrich operates in 40 countries and has 7,600 employees providing excellent service worldwide. Sigma-Aldrich is committed to Accelerating Customer Success through Innovation and Leadership in Life Science, High Technology and Service. For more information about Sigma-Aldrich, please visit its award-winning Web site at http://www.sigma-aldrich.com.
Sigma-Aldrich is a registered trademark of Sigma-Aldrich Biotechnology L.P. and Sigma-Aldrich Co.
Page: 1 2 Related biology technology :1
|SOURCE Sigma-Aldrich Corporation|
Copyright©2010 PR Newswire.
All rights reserved
. Sigma-Aldrich Corporation to Present at the Bairds 2010 Growth Stock Conference on Thursday, May 20, 20102
. Sigma-Aldrich (Nasdaq: SIAL) Announces Executive Management Changes: Retirement of David Julien and Promotion of Joseph Porwoll3
. Sigma-Aldrich to Present at the Bank of America Merrill Lynch 2010 Health Care Conference on Wednesday, May 12, 20104
. Sigma-Aldrich(R) Focuses on Biology With Launch of New Life Science Brand Platform5
. Sigma-Aldrich to Present at the NASDAQ OMX 23rd Investor Program on Tuesday, December 1, 20096
. Sigma-Aldrich (Nasdaq: SIAL) Declares Quarterly Dividend7
. Sigma-Aldrich(R) and Sangamo BioSciences Announce Major Expansion of ZFP Technology License Agreement8
. Sigma-Aldrich Elects George M. Church as Director9
. Sigma-Aldrich to Present at the UBS Global Life Sciences Conference on Monday, September 21, 200910
. BioLife Solutions Announces HypoThermosol(R) and CryoStor(TM) Distribution Agreement With Sigma-Aldrich11
. Sigma-Aldrich to Present at the Thomas Weisel Healthcare Conference on Thursday, September 10, 2009